Bilosomes in the context of oral immunization: Development, challenges and opportunities

Drug Discovery Today

Volumn 21, Issue 6, 2016, Pages 888-899

  Shukla, Anshuman ^a   Mishra, Vijay ^b   Kesharwani, Prashant ^c  

^a PANJAB UNIVERSITY   (India)

^b ADINA Institute of Pharmaceutical Sciences   (India)

^c WAYNE STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BILE SALT; BILOSOME; DIPHTHERIA VACCINE; ENZYME; HEPATITIS B VACCINE; INFLUENZA VACCINE; LIPOSOME; NIOSOME; NONIONIC SURFACTANT; TETANUS TOXOID; UNCLASSIFIED DRUG; BILE ACID;

DRUG DELIVERY SYSTEM; DRUG FORMULATION; FILM; HUMAN; HYDRATION; IMMUNIZATION; NONHUMAN; PATIENT COMPLIANCE; PEYER PATCH; REVIEW; SCALE UP; STOMACH ACID; SURFACE PROPERTY; ANIMAL; METABOLISM; ORAL DRUG ADMINISTRATION; PROCEDURES;

ADMINISTRATION, ORAL; ANIMALS; BILE ACIDS AND SALTS; HUMANS; IMMUNIZATION; LIPOSOMES; PEYER'S PATCHES;

EID: 84962148649     PISSN: 13596446     EISSN: 18785832     Source Type: Journal    
DOI: 10.1016/j.drudis.2016.03.013     Document Type: Review

References (51)

1. L. Jodar, and et al. Ensuring vaccine safety in immunization programmes - a WHO perspective Vaccine 19 2001 1594 1605
2. WHO State of the World's Vaccines and Immunization 2009 Available at: http://www.who.int/immunization/sowvi/en/
3. E.L. Giudice, and J.D. Campbell Needle-free vaccine delivery Adv. Drug Deliv. Rev. 58 2006 68 89
4. A. Shukla, and et al. M-cell targeted delivery of recombinant hepatitis B surface antigen using cholera toxin B subunit conjugated bilosomes Int. J. Pharm. 385 2010 47 52
5. A. Shukla, and et al. Oral immunization against hepatitis B using bile salt stabilized vesicles (bilosomes) J. Pharm. Pharm. Sci. 11 2008 59 66
6. K. Suzuki, and et al. GALT: organization and dynamics leading to IgA synthesis Adv. Immunol. 107 2010 153 185
7. O. Borges, and et al. Mucosal vaccines: recent progress in understanding the natural barriers Pharm. Res. 27 2009 211 223
8. L.B. Lawson, and et al. Defending the mucosa: adjuvant and carrier formulations for mucosal immunity Curr. Opin. Immunol. 23 2011 414 420
9. B.P. Vickery, and et al. Mechanisms of immune tolerance relevant to food allergy J. Allergy Clin. Immunol. 127 2010 576 584
10. A. Vujanic, and et al. Combined mucosal and systemic immunity following pulmonary delivery of ISCOMATRIX™ adjuvanted recombinant antigens Vaccine 28 2010 2593 2597
11. W. Atkinson, and et al. Epidemiology and Prevention of Vaccine-Preventable Diseases 2011 Public Health Foundation
12. S. Murch, and et al. Gastrointestinal mucosal immunology and mechanisms of inflammation R. Wyllie, Pediatric Gastrointestinal and Liver Disease 4th edn 2011 W.B. Saunders 50 63
13. C.A. Da Silva, and et al. Chitin particles are multifaceted immune adjuvants Am. J. Respir. Crit. Care Med. 182 2010 1482 1491
14. N. Mishra, and et al. Lectin anchored PLGA nanoparticles for oral mucosal immunization against hepatitis B J. Drug Target. 19 2010 67 78
15. M.O. Oyewumi, and et al. Nano-microparticles as immune adjuvants: correlating particle sizes and the resultant immune responses Expert Rev. Vaccines 9 2010 1095 1107
16. M.-L. De Temmerman, and et al. Particulate vaccines: on the quest for optimal delivery and immune response Drug Discov. Today 16 2011 569 582
17. M. Ann Clark, and et al. Targeting polymerised liposome vaccine carriers to intestinal M cells Vaccine 20 2001 208 217
18. W.S.W. Shalaby Development of oral vaccines to stimulate mucosal and systemic immunity: barriers and novel strategies Clin. Immunol. Immunopathol. 74 1995 127 134
19. M. Conacher, and et al. Oral immunisation with peptide and protein antigens by formulation in lipid vesicles incorporating bile salts (bilosomes) Vaccine 19 2001 2965 2974
20. J.F.S. Mann, and et al. Optimisation of a lipid based oral delivery system containing A/Panama influenza haemagglutinin Vaccine 22 2004 2425 2429
21. J.F.S. Mann, and et al. Oral delivery of tetanus toxoid using vesicles containing bile salts (bilosomes) induces significant systemic and mucosal immunity Methods 38 2006 90 95
22. A. Shukla, and et al. Nano-bilosomes as potential vaccine delivery system for effective combined oral immunization against tetanus and hepatitis B J. Biotechnol. 150 2010 98 99
23. A. Shukla, and et al. Significant systemic and mucosal immune response induced on oral delivery of diphtheria toxoid using nano-bilosomes Brit. J. Pharmacol. 164 2011 820 827
24. J. McGhee, and J. Mestecky In defense of mucosal surfaces. Development of novel vaccines for IgA responses protective at the portals of entry of microbial pathogens Infect. Dis. Clin. North Am. 4 1990 315 341
25. J.R. McGhee, and et al. The mucosal immune system: from fundamental concepts to vaccine development Vaccine 10 1992 75 88
26. M.R. Neutra, and et al. Antigen sampling across epithelial barriers and induction of mucosal immune responses Annu. Rev. Immunol. 14 1996 275 300
27. N.M. Csaba, and et al. The performance of nanocarriers for transmucosal drug delivery Expert Opin. Drug Deliv. 3 2006 463 478
28. J.S. Wilkhu, and et al. Characterization and optimization of bilosomes for oral vaccine delivery J. Drug Target. 21 2013 291 299
29. B. Premanand, and et al. Recombinant baculovirus associated with bilosomes as an oral vaccine candidate against HEV71 infection in mice PLOS ONE 8 2013 e55536
30. R. Holm, and et al. Bile salts and their importance for drug absorption Int. J. Pharm. 453 2013 44 55
31. B. Terhaag, and U. Hermann Biliary elimination of indomethacin in man Eur. J. Clin. Pharmacol. 29 1986 691 695
32. J.R. O'Reilly, and et al. The effect of mixed micellar systems, bile salt/fatty acids, on the solubility and intestinal absorption of clofazimine (B663) in the anaesthetised rat Int. J. Pharm. 109 1994 147 154
33. J.N. Yu, and et al. Enhancement of oral bioavailability of the poorly water-soluble drug silybin by sodium cholate/phospholipid-mixed micelles Acta Pharmacol. Sin. 31 2009 759 764
34. J. Liu, and et al. Solid lipid nanoparticles loaded with insulin by sodium cholate-phosphatidylcholine-based mixed micelles: preparation and characterization Int. J. Pharm. 340 2007 153 162
35. X. Zeng, and et al. Cholic acid-functionalized nanoparticles of star-shaped PLGA-vitamin E TPGS copolymer for docetaxel delivery to cervical cancer Biomaterials 34 2013 6058 6067
36. R.M. Samstein, and et al. The use of deoxycholic acid to enhance the oral bioavailability of biodegradable nanoparticles Biomaterials 29 2008 703 708
37. F. Le Devedec, and et al. PEGylated bile acids for use in drug delivery systems: enhanced solubility and bioavailability of itraconazole Mol. Pharm. 10 2013 3057 3066
38. V.H.M. Deneer, and et al. Buccal transport of flecainide and sotalol: effect of a bile salt and ionization state Int. J. Pharm. 241 2002 127 134
39. S. Jain, and et al. Oral mucosal immunization using glucomannosylated bilosomes J. Biomed. Nanotechnol. 10 2014 932 947
40. S. Jain, and et al. Improved stability and immunological potential of tetanus toxoid containing surface engineered bilosomes following oral administration Nanomed. Nanotechnol. Biol. Med. 10 2014 431 440
41. J.F.S. Mann, and et al. Lipid vesicle size of an oral influenza vaccine delivery vehicle influences the Th1/Th2 bias in the immune response and protection against infection Vaccine 27 2009 3643 3649
42. D. Arora, and et al. Oral immunization against hepatitis B virus using mannosylated bilosomes Int. J. Rec. Adv. Pharm. Res. 1 2011 45 51
43. P. Singh, and et al. Cholera toxin B subunit conjugated bile salt stabilized vesicles (bilosomes) for oral immunization Int. J. Pharm. 278 2004 379 390
44. D. Brayden, and et al. Keynote review: intestinal Peyer's patch M cells and oral vaccine targeting Drug Discov. Today 10 2005 1145 1157
45. A. Gebert, and et al. M cells in Peyer's patches of the intestine Int. Rev. Cytol. 167 1996 91 159
46. J. Kuby Immunology 2007 W.H. Freeman and Co.
47. T.T. Macdonald, and J. Spencer Gut immunology Bailliér Clin. Gastroenterol. 4 1990 291 313
48. M.A. Clark, and et al. Exploiting M cells for drug and vaccine delivery Adv. Drug Deliv. Rev. 50 2001 81 106
49. M.A. Jepson, and et al. M cell targeting by lectins: a strategy for mucosal vaccination and drug delivery Adv. Drug Deliv. Rev. 56 2004 511 525
50. M.R. Neutra, and et al. Antigen uptake by M cells for effective mucosal vaccines H. Kryono, Mucosal Vaccines 1996 Academic Press 41 55
51. E. Bennett, and et al. Translational modifications to improve vaccine efficacy in an oral influenza vaccine Methods 49 2009 322 327